- Home
- GDO vs ANIX Comparison
GDO vs ANIX Comparison
Compare GDO & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GDO | ANIX |
|---|---|---|
| Founded | 2009 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.6M | 135.3M |
| IPO Year | N/A | 1987 |
Fundamental Metrics
Financial Performance| Metric | GDO | ANIX |
|---|---|---|
| Price | $11.84 | $3.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 39.4K | ★ 443.3K |
| Earning Date | 01-01-0001 | 01-09-2026 |
| Dividend Yield | ★ 9.81% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.21 | $2.07 |
| 52 Week High | $13.04 | $5.46 |
Technical Indicators
Market Signals| Indicator | GDO | ANIX |
|---|---|---|
| Relative Strength Index (RSI) | 61.19 | 36.03 |
| Support Level | $11.63 | $4.20 |
| Resistance Level | $11.90 | $3.64 |
| Average True Range (ATR) | 0.12 | 0.44 |
| MACD | 0.02 | -0.19 |
| Stochastic Oscillator | 93.10 | 3.73 |
Price Performance
Historical ComparisonAbout GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.